Boston Scientific Corporation (BSX)
NYSE: BSX · IEX Real-Time Price · USD
75.47
+0.82 (1.10%)
May 20, 2024, 11:22 AM EDT - Market open
Boston Scientific Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for Boston Scientific stock have an average target of 75.32, with a low estimate of 60 and a high estimate of 90. The average target predicts a decrease of -0.20% from the current stock price of 75.47.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BSX stock from 22 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 10 | 10 | 11 | 11 |
| Buy | 10 | 10 | 10 | 10 | 10 | 9 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 23 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Strong Buy Maintains $85 → $90 | Strong Buy | Maintains | $85 → $90 | +19.25% | May 15, 2024 |
| Barclays | Barclays | Buy Maintains $70 → $78 | Buy | Maintains | $70 → $78 | +3.35% | Apr 26, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $79 → $85 | Strong Buy | Maintains | $79 → $85 | +12.63% | Apr 25, 2024 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $63 → $73 | Hold | Maintains | $63 → $73 | -3.27% | Apr 25, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $72 → $82 | Buy | Maintains | $72 → $82 | +8.65% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
15.73B
from 14.24B
Increased by 10.48%
Revenue Next Year
17.20B
from 15.73B
Increased by 9.33%
EPS This Year
2.28
from 1.07
Increased by 112.64%
EPS Next Year
2.58
from 2.28
Increased by 13.36%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 16.7B | 18.5B | 20.2B | 22.0B | 23.9B |
| Avg | 15.7B | 17.2B | 18.8B | 21.0B | 22.8B |
| Low | 15.1B | 16.3B | 17.6B | 19.9B | 21.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.1% | 17.8% | 17.7% | 17.3% | 14.3% |
| Avg | 10.5% | 9.3% | 9.1% | 11.6% | 8.7% |
| Low | 6.0% | 3.6% | 2.1% | 6.2% | 3.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.43 | 2.75 | 3.14 | 3.58 | 3.97 |
| Avg | 2.28 | 2.58 | 2.90 | 3.31 | 3.69 |
| Low | 2.12 | 2.45 | 2.71 | 3.15 | 3.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 126.7% | 20.9% | 21.7% | 23.4% | 19.7% |
| Avg | 112.6% | 13.4% | 12.5% | 14.3% | 11.3% |
| Low | 97.8% | 7.7% | 5.2% | 8.4% | 6.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.